MedPath

To assess the prolongation of pain relief in children after single dose of intravenous dexmetomidine with the block given in the lowest portion of spine

Not Applicable
Conditions
Health Condition 1: null- patients undergoing urethroplasty.
Registration Number
CTRI/2018/05/013920
Lead Sponsor
AIIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA I-II

Age 2- 8 yrs

Undergoing urethroplasty

Exclusion Criteria

Parental or guardian refusal

Hypersensitivity to any local anaesthetic

Bleeding diathesis

Infection at puncture site

Children with uncorrected heart disease

Children with heart block or liver impairment

Preexisting neurological diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the effect of intravenous dexmedetomidine on caudal analgesia , to compare the time to rescue analgesia.Timepoint: The duration of analgesia is from the time of caudal injection to the time of FLACC score 4.
Secondary Outcome Measures
NameTimeMethod
To compare the incidence of emergence agitation <br/ ><br>To compare the time for discharge based on modified aldrete score. <br/ ><br>To compare the postoperative sedation. <br/ ><br>Timepoint: Sedation score will be assessed using Modified Ramsayâ??s sedation score <br/ ><br>Time taken to achieve Aldrete score of 9 will be noted.
© Copyright 2025. All Rights Reserved by MedPath